Barclays Reiterates Overweight Rating on Ionis Pharmaceuticals, Inc. (IONS)
Rating Change Barclays analysts reiterated a Overweight rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on July 10, 2026. Market Context Ionis Pharmaceuticals, Inc.
Read more
